Virtus Investment Advisers’s Apellis Pharmaceuticals APLS Stock Holding History

Virtus Investment Advisers’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,462	Closed	-$1.35M	–	467
2026 Q1	$1.35M	Buy	33,462 +6,376	+24%	+$137K	0.37%	129
2025 Q4	$680K	Buy	27,086 +4,013	+17%	+$94.2K	0.18%	185
2025 Q3	$522K	Hold	23,073	–	–	0.15%	200
2025 Q2	$399K	Buy	23,073 +12,106	+110%	+$224K	0.14%	226
2025 Q1	$240K	Buy	+10,967	New	+$303K	0.07%	253

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's APLS Position: Q2 2026 in Review

Virtus Investment Advisers sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 33,462 shares — an estimated $1.35M sold.

Virtus Investment Advisers first reported a position in APLS in Q1 2025 and held it in 5 quarters. The position peaked at $1.35M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Virtus Investment Advisers reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtus Investment Advisers sold 33,462 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.35M.
Virtus Investment Advisers first reported a position in Apellis Pharmaceuticals in Q1 2025 and held it in 5 quarters.
Virtus Investment Advisers's Apellis Pharmaceuticals position peaked at $1.35M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.